V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Zimmer Biomet Holdings Executive Compensation (FY25)

ZBH · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Ivan Tornos
Latest say-on-pay support
=
May 22, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The Zimmer Biomet Holdings brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
Data as of October 22, 2026Latest filing (8-K): May 27, 2026
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Zimmer Biomet Holdings brief$1,500Get the executive brief
Velarion Member, one year
263 figures on this page: 254 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Ivan Tornos: $14,992,868 → $16,106,550 (7.4% higher)
Say-on-pay support: 94.7% → 95.0% (0.3 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Zimmer Biomet Holdings' chief executive and what were they paid?
Total compensation for Ivan Tornos, Chairman, President and Chief Executive Officer, came to $16,106,550 in fiscal 2025. Tornos' total moved 7.4% higher from the $14,992,868 reported for fiscal 2024.
What was Zimmer Biomet Holdings' say-on-pay result?
Shareholders supported the say-on-pay proposal with 95.0% of votes cast for or against in favor at the meeting held May 22, 2026 for fiscal 2025.
Which companies are in Zimmer Biomet Holdings' peer group?
Companies named in the disclosed peer group include Agilent Technologies, Inc., Align Technology, Inc., Baxter International Inc., Becton, Dickinson and Company and Boston Scientific Corporation, among others.
What is Zimmer Biomet Holdings' chief executive pay ratio?
The company reported a chief executive pay ratio of 200:1 for fiscal 2025, against median employee compensation of $80,380.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Bryan Hanson
Chairman, President and CEO
◇—◇◇◇—◇— not reconciled
Ivan Tornos
Chief Operating Officer
◇—◇◇◇—◇◇
Suketu Upadhyay
Executive VP CFO
◇—◇◇◇—◇◇
Sang Yi
President, APAC
◇—◇◇◇—◇◇
Chad Phipps
Senior VP General Counsel and Secretary
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
◇—◇—◇—◇◇
Ivan Tornos
Chairman, President and CEO
◇—◇—◇—◇◇
Wilfred van Zuilen
Group President, EMEA
◇—◇—◇◇◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Ivan Tornos
Chairman, President and CEO
◇—◇—◇—◇◇
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
◇—◇—◇—◇◇
Wilfred van Zuilen
Group President, EMEA
◇—◇—◇◇◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Ivan Tornos
Chairman, President and Chief Executive Officer
◇—◇—◇—◇◇
Jehanzeb Noor
Senior Vice President, Chief Strategy, Business Development, Innovation and Transformation Officer
◇◇◇—◇◇◇◇
Suketu Upadhyay
Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain
◇—◇—◇—◇◇
Kevin Thornal
Group President, Global Businesses and the Americas
◇—◇—◇——◇
Wilfred van Zuilen
Group President, Europe, Middle East and Africa (EMEA)
◇—◇—◇◇◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Ivan TornosPSU◇◇◇—◇—◇
Ivan TornosRSU◇——◇——◇
Jehanzeb NoorPSU◇◇◇—◇—◇
Jehanzeb NoorRSU◇——◇——◇
Jehanzeb NoorPSU◇◇◇—◇—◇
Jehanzeb NoorRSU◇——◇——◇
Kevin ThornalPSU◇◇◇—◇—◇
Kevin ThornalRSU◇——◇——◇
Suketu UpadhyayPSU◇◇◇—◇—◇
Suketu UpadhyayRSU◇——◇——◇
Wilfred van ZuilenPSU◇◇◇—◇—◇
Wilfred van ZuilenRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Wilfred van ZuilenPSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Kevin ThornalPSU◇◇——
RSU◇◇——
Suketu UpadhyayPSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Jehanzeb NoorRSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Ivan TornosRSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Kevin Thornal
Group President, Global Businesses and the Americas · Change-in-control agreement · dated May 20, 2025
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation on change in control◇
Benefits continuation◇
Clawback◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Sreelakshmi Kolli
◇◇———◇◇
Louis A. Shapiro
◇◇———◇◇
Devdatt Kurdikar
◇◇———◇◇
Michael J. Farrell
Lead independent director
◇◇———◇◇
Robert A. Hagemann
◇◇———◇◇
Syed Jafry
◇◇———◇◇
Betsy J. Bernard
◇◇———◇◇
Arthur J. Higgins
◇◇———◇◇
Maria Teresa Hilado
◇◇———◇◇
Christopher B. Begley
◇————◇◇
Ivan Tornos served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Equity is delivered as restricted stock units and deferred stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Agilent Technologies, Inc. A
  • Align Technology, Inc. ALGN
  • Baxter International Inc. BAX
  • Becton, Dickinson and Company BDX
  • Boston Scientific Corporation BSX
  • DexCom, Inc. DXCM
  • Edwards Lifesciences Corporation EW
  • Hologic, Inc. HOLX
  • Intuitive Surgical, Inc. ISRG
  • Laboratory Corporation of America Holdings symbol not shown
  • Quest Diagnostics Incorporated DGX
  • Stryker Corporation SYK
  • Teleflex Incorporated TFX
  • The Cooper Companies, Inc. COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 22, 2026=◇◇◇
2024May 29, 2025=◇◇◇
2023May 10, 2024=◇◇◇
2022May 12, 2023=◇◇◇
2021May 13, 2022=◇◇◇
2020May 14, 2021=◇◇◇
2019May 8, 2020=◇◇◇
2018May 10, 2019=◇◇◇
2017May 15, 2018=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Ivan Tornos (Chairman, President and Chief Executive Officer), FY2025 total compensation $16,106,550 (base salary $1,281,846) [exec_comp, SEC accession 0001193125-26-135661, filed 2026-04-01]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Zimmer Biomet Holdings files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Zimmer Biomet Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Zimmer Biomet Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Zimmer Biomet Holdings' disclosed peer group is defensible, who names Zimmer Biomet Holdings back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
263 figures on this page: 254 cited to the filing that reported them, 9 calculated from figures it prints.
254 cited to the filing
9 calculated from the filing

Documents cited

  1. 0001193125-26-242207
  2. 0001193125-26-135661
    2025 CEO Pay Ratio · 2025 Director Compensation Table · 2025 Summary Compensation Table · Compensation of Non-Employee Directors · and 2 more sections
  3. 0000950170-25-080567
  4. 0001193125-25-126231
    EX-10.1
  5. 0000950170-25-053494
    2024 Summary Compensation Table
  6. 0000950170-24-060580
  7. 0000950170-24-037305
    2023 Summary Compensation Table
  8. 0001193125-23-146173
  9. 0001193125-23-085733
    2022 Summary Compensation Table
  10. 0001193125-22-154485
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”) For Against Abstain Broker Non-Votes
  11. 0001193125-21-167789
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”) For Against Abstain Broker Non-Votes
  12. 0001564590-20-025055
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”) For Against Abstain Broker Non-Votes
  13. 0001564590-19-019629
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”) For Against Abstained Broker Non-Votes
  14. 0001564590-18-014092
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”) For Against Abstained Broker Non-Votes
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Zimmer Biomet Holdings executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/ZBH (accessed 2026).
Short form: data: Velarion

The Zimmer Biomet Holdings brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Zimmer Biomet Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Zimmer Biomet Holdings discloses

The companies named in ZBH's own disclosed peer group.

Agilent Technologies, Inc.Align Technology, Inc.Baxter International Inc.Becton, Dickinson and CompanyBoston Scientific CorporationDexCom, Inc.Edwards Lifesciences CorporationHologic, Inc.Intuitive Surgical, Inc.Quest Diagnostics IncorporatedStryker CorporationTeleflex IncorporatedThe Cooper Companies, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy